A Structured, Education-First Pathway for Modern Clinics

Specialty-Specific Programs.

These specialty-specific programs outline how stem cell therapy discussions are applied within different areas of clinical practice. Each program focuses on the conditions most commonly encountered within a given specialty and explains how stem cell–based care may be evaluated, discussed, and documented alongside standard treatment options, within appropriate clinical and regulatory boundaries.

Physicians reviewing clinical and laboratory data related to biologic treatment considerations.

Program Overview

An Education-Based Framework for Specialty-Specific Clinical Integration.

This framework provides structured, specialty-specific guidance for how regenerative and stem cell–related care discussions may be incorporated into clinical practice across different medical disciplines.

Rather than applying a single, generalized approach, these programs account for the diagnostic priorities, patient populations, and clinical workflows unique to each specialty.

In application, this framework supports physicians in:

  • Aligning regenerative care discussions with specialty-specific evaluation and diagnostic standards
  • Identifying appropriate clinical contexts and patient selection considerations
  • Integrating biologic and regenerative concepts alongside established treatment pathways
  • Maintaining consistent, compliant communication across providers and care teams
  • Addressing regulatory, documentation, and risk considerations relevant to each specialty

What Makes This Program Different

How Specialty-Specific Programs Are Applied in Clinical Practice

Most Specialty-Specific programs focus on procedures, pricing, or volume. Synergy focuses on foundation first. Our program is built around four pillars:

Who This Program Is For

Clinics Using Specialty-Specific Clinical Education.

This program is designed for physicians and practices that rely on structured, specialty-aligned education to guide patient discussions, evaluation, and care planning within established standards of care.

It is commonly used by:

  • Orthopedic practices integrating advanced education into surgical and non-surgical treatment planning
  • Pain management clinics supporting chronic and complex pain evaluations

  • Sports medicine practices addressing recovery, joint health, and active patient needs


  • Family and general practice clinics guiding referrals and coordinated care decisions
  • Multispecialty and referral-based clinics seeking consistent, standardized clinical communication
Laboratory specialist performing controlled pipetting as part of biologic material preparation.

Patient-Facing Philosophy

Clear Education Builds Patient Confidence.

Patients are informed and cautious. Effective clinical discussions rely on clear, ethical education grounded in evidence, clinical context, and realistic expectations — not promises.

These pathways support patient conversations around:

  • What advanced biologic and regenerative approaches may support
  • What current clinical evidence shows — and where it remains limited
  • Why patient selection, diagnosis, and specialty context matter
  • Why conservative, evidence-aligned recommendations are often appropriate

By prioritizing transparent explanation and careful expectation-setting, clinics support informed decision-making, regulatory alignment, and long-term patient trust.

Built for Growth — Without Regulatory Anxiety.

The Synergy Regenerative Medicine Program is designed to support responsible growth while preserving clinical independence. Participating physicians maintain full autonomy, control all patient decisions, and retain complete ownership of their protocols and practice.

Education

Clear, clinically relevant guidance on stem cell biology, appropriate use discussions, and regulatory considerations.

Structure

Explicit clinical boundaries that support ethical communication, proper documentation, and risk awareness.

Guardrails

Defined care pathways that align with existing diagnostic, treatment planning, and follow-up workflows.

Strategic Support

Ongoing clinical and compliance-focused guidance as stem cell therapy pathways evolve in practice.

Built for Growth.

At Synergy, our focus has always been helping physicians adopt regenerative medicine in a way that protects their license, their patients, and their long-term practice.

Perry Myers

Founder – Synergy

Clarity Over Hype.

Synergy exists to give physicians a clear, defensible path into regenerative medicine. Everything we build prioritizes patient trust, clinical judgment, and long-term sustainability.

James Finnegan

Founder – Synergy

Why Clinics Choose Synergy.

A physician-first approach to regenerative medicine — combining education, structure, compliance, and responsible marketing.

  • Education-based discussion of stem cell therapy

  • Clear guidance on when discussion may be appropriate

  • Physician-led evaluation and decision-making

  • Structured patient conversations and consent support

  • Alignment with Evolving Regulatory Guidance

  • No Exaggerated Claims or Outcome Promises

  • Built to Integrate Into Existing Workflows

  • Designed for Long-Term Adoption, not Trends

  • Compliance-Aware Marketing Guidance

Other Regenerative Programs

  • Procedure-driven models with minimal education

  • Vague or aggressive patient messaging

  • One-size-fits-all protocols

  • Little to no compliance oversight

  • Pressure to over-sell regenerative services

  • Poor integration with clinic branding

  • Short-term focus with long-term risk

  • Increased risk of regulatory scrutiny

  • Potential exposure to board complaints and audits

  • Risk to professional license if implemented improperly

Want a Zoom Call With Our Team?

We’ll walk through education, operational support, and what “done by the book” really looks like—no pressure, no obligation.

What Happens When Guardrails Are Missing

3 charged with performing unlicensed stem cell operations in Draper

By Pat Reavy, KSL | Posted – Dec. 17, 2025 at 8:04 p.m.

DRAPER — Three people, including a licensed orthopedic surgeon and another man whose license was revoked years ago, are accused of performing unlicensed stem cell operations in Draper.

AG Ferguson files lawsuit against US Stemology for peddling unproven, untested stem cell treatments

By Brionna Aho, Washington State | Posted – Mar 15 2022

OLYMPIA — Attorney General Bob Ferguson filed a lawsuit against Seattle-based US Stemology and its owner, Dr. Tami Meraglia, for deceptively marketing stem cell treatments for COVID-19

Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million

By Mitchell J. Katz, ftc.gov | Posted – January 8, 2025

Under federal district court orders announced today, the co-founders of the Stem Cell Institute of America and several related companies are banned from marketing stem cell therapy in the future.

Get a personal consultation.